Protocol: Influence of Budesonide and Budesonide/Formoterol on asthma control in smoking asthmatic adults

Open Respiratory Medicine Journal

Volumn 4, Issue , 2010, Pages 51-57

  Boulet, Louis Philippe ^a   Deschesnes, Francine ^a   Chaboillez, Simone ^b   Lemière, Catherine ^b  

^a LAVAL UNIVERSITY   (Canada)

^b HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

Author keywords

Asthma; Budesonide; Formoterol; Smoking

Indexed keywords

BUDESONIDE; CORTICOSTEROID; FORMOTEROL;

ADULT; ARTICLE; ASTHMA; ASTHMA CONTROL QUESTIONNAIRE; ASTHMA QUALITY OF LIFE QUESTIONNAIRE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE CONTROL; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FORCED VITAL CAPACITY; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PEAK EXPIRATORY FLOW; PRICK TEST; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFLAMMATION; SMOKING; SPIROMETRY;

EID: 84877009447     PISSN: None     EISSN: 18743064     Source Type: Journal    
DOI: 10.2174/1874306401004010051     Document Type: Article

References (28)

1. Jha P, Ranson MK, Nguyen SN, Yach D. Estimates of global and regional smoking prevalence in 1995, by age and sex. Am J Public Health 2002; 92: 1002-6.
2. Respiratory disease in Canada. Canadian Institute for Health Information, Canadian Lung Association, Health Canada, Statistics, Ottawa, Canada, September 2001. Available from: http://secure.cihi.ca/cihiweb/dispPage.jsp?cwpage=AR13E
3. Thomson NC, Chaudhuri R, Livingston E. Active cigarette smoking and asthma. Clin Exp Allergy 2003; 33: 1471-5.
4. Lemiere C, Boulet LP. Cigarette smoking and asthma: a dangerous mix. Can Respir J 2005; 12: 79-80.
5. Althuis M, Sexton M, Prybylski D. Cigarette smoking and asthma severity among adult asthmatics. J Asthma 1999; 36: 257-64.
6. Ulrik CS, Lange P. Cigarette smoking and asthma. Monaldi Arch Chest Dis 2001; 56: 349-53.
7. Lange P, Parner J, Vestbo J, Schnohr P, Jensen G. A 15 year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998; 339: 1194-200.
8. Siroux V, Pin I, Oryszczyn M, Le Moual N, Kauffman F. Relationships of active smoking to asthma and asthma severity in the EGEA study. Epidemiological study on the Genetics and Environment of Asthma. Eur Respir J 2000; 15: 470-7.
9. Thomson NC. Smokers with asthma: what are the management options? Am J Respir Crit Care Med 2007; 175: 749-50.
10. Boulet LP, Lemiere C, Archambault F, Carrier G, Descary MC, Deschesnes F. Smoking and asthma: clinical and radiologic features, lung function, and airway inflammation. Chest 2006; 129: 661-8.
11. Pedersen B, Dahl R, Karlstrom R, Peterson CG, Venge P. Eosinophil and neutrophil activity in asthma in a one-year trial with inhaled budesonide: the impact of smoking. Am J Respir Crit Care Med 1996; 153: 1519-29.
12. Chalmers GW, Macleod KJ, Little SA, Thomson LJ, McSharry CP, Thomson NC. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma. Thorax 2002; 57: 226-30.
13. Chalmers GW, MacLeod KJ, Thomson L, Little SA, McSharry C, Thomson NC. Smoking and airway inflammation in patients with mild asthma. Chest 2001; 120: 1917-22.
14. Global Initiatives on Asthma (GINA guidelines) www.ginasthma.com
15. Lemière C, Bai T, Balter M, et al. Adult Asthma Consensus Guidelines Update 2003. Can Respir J 2004; 11: 9A-18A.
16. American Thoracic Society: Standards for the diagnosis of patients with COPD and asthma. Am Rev Respir Dis 1987; 136: 225-44.
17. Leblanc A, Robichaud P, Lacasse Y, Boulet LP. Quantification of asthma control: validation of the Asthma Control Scoring System. Allergy 2007; 62: 120-5.
18. Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999; 14: 902-7.
19. Juniper EF, Guyatt GH, Cox FM, Ferrie PJ, King DR. Development and validation of the mini asthma quality of life questionnaire. Eur Respir J 1999; 14: 32-8.
20. ATS statement. Standardization of spirometry-1987 update. Am Rev Respir Dis 1987; 136: 1285-98.
21. Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 1983; 127: 725-34.
22. Juniper EF, Cockcroft DW, Hargreave FE. Eds. Astra Draco AB. Histamine and Methacholine inhalation Tests: A laboratory Tidal Breathing Protocol. Lund, Sweden 1991.
23. Pizzichini E, Hargreave FE, Pizzichini E, et al. Assessment of airway inflammation. In: Barnes P, Grunstein M, Leff A, Woolcock A, Eds. Asthma. Philadelphia PA: Lippincott-Raven 1997; vol. 2: pp. 1433-50.
24. Woolcock A, Lundback B, Ringdal N, Jacques LA. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med 1996; 153: 1481-8.
25. O'Byrne PM, Barnes PJ, Rodriguez-Roisin R, et al. A low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. Am J Respir Crit Care Med 2001; 164: 1392-7.
26. Thomson NC, Shepherd M, Spears M, Chaudhuri R. Corticosteroid insensitivity in smokers with asthma: clinical evidence, mechanisms, and management. Treat Respir Med 2006; 5: 467-81.
27. Thomson NC, Chaudhuri R, Livingston E. Asthma and cigarette smoking. Eur Respir J 2004; 24: 822-33.
28. Lazarus SC, Chinchilli VM, Rollings NJ, et al. National heart lung and blood institute's asthma clinical research network. Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma. Am J Respir Crit Care Med 2007; 175: 783-90.